This month, CDDF marks 25 years of turning hope into action and challenges into progress.
Throughout this time, CDDF has served as a unique, neutral platform — a non-competitive, trusted space where researchers, clinicians, patients, the pharmaceutical industry, regulators, and HTA bodies convene to address challenges and opportunities in oncology drug development together.
We extend our gratitude to our collaborators, industry members, staff, and board members — past and present. Their expertise and unwavering commitment have shaped CDDF into what it is today and remain vital to our pursuit of effective treatments for patients.
As we celebrate this milestone, we look forward to continuing our mission of improving patient outcomes, together with you.